Home / Market Reports / Medical Devices & Consumables / Global Large Volume Parenteral (LVP) Market Growth 2023-2029

Global Large Volume Parenteral (LVP) Market Growth 2023-2029

Global Large Volume Parenteral (LVP) Market Growth 2023-2029

Product Code:456371

Published Date: Feb 08,2023

Pages: 116

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.  Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

LPI (LP Information)' newest research report, the “Large Volume Parenteral (LVP) Industry Forecast” looks at past sales and reviews total world Large Volume Parenteral (LVP) sales in 2022, providing a comprehensive analysis by region and market sector of projected Large Volume Parenteral (LVP) sales for 2023 through 2029. With Large Volume Parenteral (LVP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Large Volume Parenteral (LVP) industry.

This Insight Report provides a comprehensive analysis of the global Large Volume Parenteral (LVP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Large Volume Parenteral (LVP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Large Volume Parenteral (LVP) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Large Volume Parenteral (LVP) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Large Volume Parenteral (LVP).

The global Large Volume Parenteral (LVP) market size is projected to grow from US$ 10300 million in 2022 to US$ 13790 million in 2029; it is expected to grow at a CAGR of 13790 from 2023 to 2029.

The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.

This report presents a comprehensive overview, market shares, and growth opportunities of Large Volume Parenteral (LVP) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Soft Bag LVP
    Plastic Bottle LVP
    Glass Bottle LVP

Segmentation by application
    Basic Infusion
    Therapeutic Infusion
    Nutritious Infusion

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Baxter Healthcare
    Kelun Pharma
    B. Braun
    Fresenius
    Teva Pharmaceutical Industries
    Pfizer (Hospira)
    Ostuka Pharmaceutical
    CR Double-Crane
    Pisa
    Huaren
    Patheon
    Beximco Pharma
    Albert David
    PSI Ltd
    Ozon Pharmaceuticals
    BAG Healthcare
    BML Parenteral Drugs

Key Questions Addressed in this Report
What is the 10-year outlook for the global Large Volume Parenteral (LVP) market?
What factors are driving Large Volume Parenteral (LVP) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Large Volume Parenteral (LVP) market opportunities vary by end market size?
How does Large Volume Parenteral (LVP) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?